Cargando…

Guide to Targeted Therapies: Treatment Resistance in Lung Cancer

This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Cappuzzo, Federico (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cham : Springer International Publishing : Imprint: Adis, 2015.
Edición:1st ed. 2015.
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-319-20741-4
003 DE-He213
005 20220116193411.0
007 cr nn 008mamaa
008 151015s2015 sz | s |||| 0|eng d
020 |a 9783319207414  |9 978-3-319-20741-4 
024 7 |a 10.1007/978-3-319-20741-4  |2 doi 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 616.994  |2 23 
100 1 |a Cappuzzo, Federico.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Guide to Targeted Therapies: Treatment Resistance in Lung Cancer  |h [electronic resource] /  |c by Federico Cappuzzo. 
250 |a 1st ed. 2015. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Adis,  |c 2015. 
300 |a VII, 67 p. 14 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Introduction -- Therapy options for advanced NSCLC -- Resistance to EGFR TKIs -- Overcoming EGFR-TKI resistance -- Resistance to crizotinib and therapeutic options -- Resistance to angiogenic drugs and therapeutics options.- Conclusions. 
520 |a This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of treatment resistance in lung cancer as well as a summary of current therapies will benefit from this succinct guide. 
650 0 |a Oncology. 
650 1 4 |a Oncology. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783319207407 
776 0 8 |i Printed edition:  |z 9783319207421 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-319-20741-4  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)